280 related articles for article (PubMed ID: 30952736)
21. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
[TBL] [Abstract][Full Text] [Related]
22. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
23. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
[TBL] [Abstract][Full Text] [Related]
24. Frequency and Evolution of Acute Oral Complications in Patients Undergoing Radiochemotherapy Treatment for Head and Neck Squamous Cell Carcinoma.
Palmieri M; Sarmento DJS; Falcão AP; Martins VAO; Brandão TB; Morais-Faria K; Ribeiro ACP; Hasséus B; Giglio D; Braz-Silva PH
Ear Nose Throat J; 2021 Sep; 100(5_suppl):449S-455S. PubMed ID: 31619067
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of basic oral care for the management of oral mucositis in cancer patients.
McGuire DB; Fulton JS; Park J; Brown CG; Correa ME; Eilers J; Elad S; Gibson F; Oberle-Edwards LK; Bowen J; Lalla RV;
Support Care Cancer; 2013 Nov; 21(11):3165-77. PubMed ID: 24018908
[TBL] [Abstract][Full Text] [Related]
26. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
Ertekin MV; Koç M; Karslioglu I; Sezen O
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
[TBL] [Abstract][Full Text] [Related]
27. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
[TBL] [Abstract][Full Text] [Related]
28. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial.
Huang BS; Wu SC; Lin CY; Fan KH; Chang JT; Chen SC
Eur J Cancer Care (Engl); 2018 Mar; 27(2):e12819. PubMed ID: 29315944
[TBL] [Abstract][Full Text] [Related]
30. Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.
Marucci L; Farneti A; Di Ridolfi P; Pinnaro P; Pellini R; Giannarelli D; Vici P; Conte M; Landoni V; Sanguineti G
Head Neck; 2017 Sep; 39(9):1761-1769. PubMed ID: 28560780
[TBL] [Abstract][Full Text] [Related]
31. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
[TBL] [Abstract][Full Text] [Related]
33. Sucralfate in the prevention of radiation-induced oral mucositis.
Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
[TBL] [Abstract][Full Text] [Related]
34. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
Limaye SA; Haddad RI; Cilli F; Sonis ST; Colevas AD; Brennan MT; Hu KS; Murphy BA
Cancer; 2013 Dec; 119(24):4268-76. PubMed ID: 24114811
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer.
Kin-Fong Cheng K; Ka Tsui Yuen J
Cancer Nurs; 2006; 29(5):423-30. PubMed ID: 17006117
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a Lactobacillus brevis strain with potential oral probiotic properties.
Fang F; Xu J; Li Q; Xia X; Du G
BMC Microbiol; 2018 Dec; 18(1):221. PubMed ID: 30577728
[TBL] [Abstract][Full Text] [Related]
37. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).
Leenstra JL; Miller RC; Qin R; Martenson JA; Dornfeld KJ; Bearden JD; Puri DR; Stella PJ; Mazurczak MA; Klish MD; Novotny PJ; Foote RL; Loprinzi CL
J Clin Oncol; 2014 May; 32(15):1571-7. PubMed ID: 24733799
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic management of radiation-induced mucositis using herbal mouthwash in patients with head and neck cancer: an assessor-blinded randomized controlled trial.
Kongwattanakul S; Petchann N; Petroch P; Thanthong S; Tungfung S; Chamchod S; Pitiporn S; Nantajit D
J Complement Integr Med; 2022 Sep; 19(3):771-780. PubMed ID: 35218685
[TBL] [Abstract][Full Text] [Related]
39. [The timing of the appearance of oral mucositis induced by concurrent chemoradiotherapy with S-1 for head and neck cancer].
Yonekita H; Takase H; Ogata K; Futagami K; Nomoto S; Yoshimitsu K; Nakagawa T; Tokunaga S
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2571-5. PubMed ID: 25596050
[TBL] [Abstract][Full Text] [Related]
40. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
Sio TT; Blanchard MJ; Novotny PJ; Patel SH; Rwigema JM; Pederson LD; McGee LA; Gamez ME; Seeger GR; Martenson JA; Grover Y; Neben Wittich MA; Garces YI; Foote RL; Miller RC; Halyard MY
Mayo Clin Proc; 2019 Sep; 94(9):1814-1824. PubMed ID: 31405750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
